Thus, the authors hypothesize that ME/CFS results from CRFR2 upregulations in specific neurons of the raphé nuclei and limbic system, leading to a loss of homeostatic control over the functions mediated by those neurons. The gene discussed is CRHR2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.